Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coartem in children with uncomplicated malaria (Mozambique)
NCT06970600Completed
- Sponsor
- Manhiça Health Research Centre
- Start
- Mar 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lumefantrine in malaria, sponsored by Manhiça Health Research Centre. Primary endpoint: Day 28 PCR corrected cure rate. Started Mar 2024; status: completed.
02
Drugs
lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT06970600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06970600.